Correlation Between Bellus Health and Brickell Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bellus Health and Brickell Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellus Health and Brickell Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bellus Health and Brickell Biotech, you can compare the effects of market volatilities on Bellus Health and Brickell Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellus Health with a short position of Brickell Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellus Health and Brickell Biotech.

Diversification Opportunities for Bellus Health and Brickell Biotech

  Correlation Coefficient

Pay attention - limited upside

The 12 months correlation between Bellus and Brickell is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Bellus Health and Brickell Biotech in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Brickell Biotech and Bellus Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellus Health are associated (or correlated) with Brickell Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brickell Biotech has no effect on the direction of Bellus Health i.e., Bellus Health and Brickell Biotech go up and down completely randomly.

Pair Corralation between Bellus Health and Brickell Biotech

Considering the 90-day investment horizon Bellus Health is expected to generate 0.77 times more return on investment than Brickell Biotech. However, Bellus Health is 1.3 times less risky than Brickell Biotech. It trades about 0.09 of its potential returns per unit of risk. Brickell Biotech is currently generating about -0.06 per unit of risk. If you would invest  366.00  in Bellus Health on February 17, 2022 and sell it today you would earn a total of  514.00  from holding Bellus Health or generate 140.44% return on investment over 90 days.
Time Period12 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Bellus Health  vs.  Brickell Biotech

 Performance (%) 
Bellus Health 
Bellus Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bellus Health are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Bellus Health unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bellus Price Channel

Brickell Biotech 
Brickell Performance
0 of 100
Over the last 90 days Brickell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in June 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Brickell Price Channel

Bellus Health and Brickell Biotech Volatility Contrast

 Predicted Return Density 

Pair Trading with Bellus Health and Brickell Biotech

The main advantage of trading using opposite Bellus Health and Brickell Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellus Health position performs unexpectedly, Brickell Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will offset losses from the drop in Brickell Biotech's long position.
The idea behind Bellus Health and Brickell Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Directory
Find actively traded corporate debentures issued by US companies